Cargando…
Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance
An effective prophylactic hepatitis B virus (HBV) vaccine has long been available but is ineffective for chronic infection. The primary cause of chronic hepatitis B (CHB) and greatest impediment for a therapeutic vaccine is the direct and indirect effects of immune tolerance to HBV antigens. The res...
Autores principales: | Whitacre, DC, Peters, CJ, Sureau, C, Nio, K, Li, F, Su, L, Jones, JE, Isogawa, M, Sallberg, M, Frelin, L, Peterson, DL, Milich, DR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062423/ https://www.ncbi.nlm.nih.gov/pubmed/31809638 http://dx.doi.org/10.1080/21645515.2019.1689745 |
Ejemplares similares
-
Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination
por: Brass, Anette, et al.
Publicado: (2015) -
A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans
por: Frelin, Lars, et al.
Publicado: (2009) -
P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections
por: Whitacre, David C., et al.
Publicado: (2015) -
Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
por: Ahlén, G, et al.
Publicado: (2009) -
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses
por: Holmström, Fredrik, et al.
Publicado: (2016)